Journal of Medicinal Chemistry p. 1242 - 1248 (1989)
Update date:2022-08-05
Topics:
Gray, Nancy M.
Cheng, Brian K.
Mick, Stephen J.
Lair, Cecelia M.
Contreras, Patricia C.
A series of 1,2,3,4-tetrahydroisoquinolines, tetrahydrothieno<2,3-c>pyridines, and related compounds were evaluated for their ability to inhibit binding of <(3)H>-1-<1-(2-thienyl)piperidine and <(3)H>-N-allylnormetazocine to phencyclidine (PCP) and ? receptors, respectively.A representative series of compounds was evaluated in behavioral assays to determine the ability of the compounds to induce PCP-like stereotyped behavior and ataxia.All of the compounds caused stereotyped behavior and ataxia, indicating their agonist actions at the PCP site.
View MoreWuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
website:http://www.maisonchem.com.cn
Contact:0086-311-83833777
Address:Leitou industrial district, xinji, shijiazhuang city, hebei province,
Doi:10.1039/c7ob00177k
(2017)Doi:10.1016/S0040-4039(01)80167-2
(1984)Doi:10.1021/jo00429a022
(1977)Doi:10.1016/S0040-4039(03)01715-5
(2003)Doi:10.1016/0040-4020(76)85211-8
(1976)Doi:10.1016/S0968-0896(03)00057-9
(2003)
